Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema

[1]  M. Triggiani,et al.  Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group , 2014, Allergy.

[2]  G. Porebski,et al.  The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach? , 2013, Allergy.

[3]  H. Farkas.  Current pharmacotherapy of bradykinin-mediated angioedema , 2013, Expert opinion on pharmacotherapy.

[4]  R. Lockey,et al.  WAO Guideline for the Management of Hereditary Angioedema , 2012, The World Allergy Organization journal.

[5]  J. Stockman.  Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2012 .

[6]  B. Chipps.  Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2011, Pediatrics.

[7]  H. Farkas,et al.  Long‐term efficacy of danazol treatment in hereditary angioedema , 2011, European journal of clinical investigation.

[8]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[9]  H. Farkas,et al.  The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study , 2010, European Journal of Clinical Pharmacology.

[10]  H. Farkas,et al.  Disease expression in women with hereditary angioedema. , 2008, American journal of obstetrics and gynecology.

[11]  H. Farkas,et al.  Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients. , 2008, Atherosclerosis.

[12]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  M. López-Trascasa,et al.  Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. , 2008, The Journal of allergy and clinical immunology.

[14]  B. Zuraw.  Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  A. Sheffer,et al.  Hereditary angioedema: Safety of long-term stanozolol therapy. , 2007, The Journal of allergy and clinical immunology.

[16]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[17]  L. Romics,et al.  Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.

[18]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[19]  M. Cicardi,et al.  Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. , 2003, Immunology letters.

[20]  N. Shahidi.  A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. , 2001, Clinical therapeutics.

[21]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[22]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[23]  M. Frank,et al.  The long-term safety of danazol in women with hereditary angioedema. , 1990, Fertility and sterility.

[24]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[25]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[26]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.